The MAPT gene encodes “microtubule-associated protein tau” which is expressed within the neurons in the brain. Mutations in the MAPT gene can exert several different effects on how this process functions. These differences in function can be unique to each specific mutation, but all result in the formation of aggregated tau inclusions, also known as tangles, which are theorized to drive neuronal loss and brain atrophy.
Learn MoreFrontotemporal Dementia (FTD) is the most common form of dementia for those under 60. Under-diagnosed and currently incurable, FTD can be caused by a mutated gene, including the MAPT gene. Cure MAPT FTD raises awareness of the MAPT genetic mutation causing FTD, assists a global network of MAPT families, and advocates for trials that will lead to a cure.
Contact UsSpread awareness of FTD, of the importance of genetic testing, and of Tau/MAPT.
Advocate for MAPT-specific trials and access to other FTD gene-specific trials.
Find, and connect to, the growing global network of MAPT families and researchers.
September 21-27, 2025
EST
Upcoming
What if it's FTD? This year's FTD Awareness Week campaign aims to raise awareness of the presenting symptoms of FTD and to contrast the disease to other forms of dementia, particularly AD (Alzheimer's Disease). We want to raise awareness of particular issues associated with FTD, for example, the younger age of onset, the greater carer burden, and the impact for families when FTD is transmitted genetically.
Are you interested in genetic testing? MAPT trials? Support and resources for FTD? Contact us and we'll get back to you quickly.
hello@curemaptftd.org